SenesTech ( (SNES) ) just unveiled an update.
On March 9, 2025, SenesTech entered into agreements with holders of existing warrants to exercise their rights at a reduced price, generating approximately $1.1 million in gross proceeds. The company will issue new short-term warrants, potentially bringing in an additional $4.3 million if fully exercised, with the proceeds intended for working capital and general corporate purposes. The transactions are facilitated by H.C. Wainwright & Co., LLC, and are subject to customary closing conditions and stockholder approval. The new warrants are unregistered and will expire eighteen months after stockholder approval, with no active trading market expected for them.
More about SenesTech
SenesTech, Inc. is a pioneer in fertility control solutions aimed at managing rodent populations. The company offers innovative products like Evolve™ rodent birth control, which are designed to enhance pest management programs by reducing reliance on traditional poisons, thereby promoting cleaner cities and healthier communities.
YTD Price Performance: -29.00%
Average Trading Volume: 171,758
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.43M
Learn more about SNES stock on TipRanks’ Stock Analysis page.